Silk Road Medical (SILK) Revenue & Revenue Breakdown
Silk Road Medical Revenue Highlights
Latest Revenue (Y)
$177.13M
Latest Revenue (Q)
$48.48M
Silk Road Medical Revenue by Period
Silk Road Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $177.13M | 27.77% |
| 2022-12-31 | $138.64M | 36.62% |
| 2021-12-31 | $101.47M | 34.89% |
| 2020-12-31 | $75.23M | 18.74% |
| 2019-12-31 | $63.35M | 83.33% |
| 2018-12-31 | $34.56M | 142.37% |
| 2017-12-31 | $14.26M | - |
Silk Road Medical generated $177.13M in revenue during NA 2023, up 27.77% compared to the previous quarter, and up 512.59% compared to the same period a year ago.
Silk Road Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $48.48M | 2.57% |
| 2023-12-31 | $47.27M | 6.38% |
| 2023-09-30 | $44.44M | -1.91% |
| 2023-06-30 | $45.30M | 12.88% |
| 2023-03-31 | $40.13M | 0.15% |
| 2022-12-31 | $40.07M | 7.21% |
| 2022-09-30 | $37.37M | 12.66% |
| 2022-06-30 | $33.17M | 18.39% |
| 2022-03-31 | $28.02M | -0.86% |
| 2021-12-31 | $28.27M | 14.43% |
| 2021-09-30 | $24.70M | -6.63% |
| 2021-06-30 | $26.46M | 19.97% |
| 2021-03-31 | $22.05M | 4.35% |
| 2020-12-31 | $21.13M | 5.31% |
| 2020-09-30 | $20.07M | 32.95% |
| 2020-06-30 | $15.09M | -20.28% |
| 2020-03-31 | $18.93M | 1.60% |
| 2019-12-31 | $18.63M | 9.44% |
| 2019-09-30 | $17.03M | 14.05% |
| 2019-06-30 | $14.93M | 16.94% |
| 2019-03-31 | $12.77M | 11.30% |
| 2018-12-31 | $11.47M | 19.31% |
| 2018-09-30 | $9.61M | 23.78% |
| 2018-06-30 | $7.77M | 36.12% |
| 2018-03-31 | $5.71M | - |
Silk Road Medical generated $48.48M in revenue during Q1 2024, up 2.57% compared to the previous quarter, and up 121.00% compared to the same period a year ago.
Silk Road Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| NARI | Inari Medical | $493.63M | $145.82M |
| TMDX | TransMedics Group | $241.62M | $114.31M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| SILK | Silk Road Medical | $177.13M | $48.48M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| RXST | RxSight | $89.08M | $45.52M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
SILK Revenue FAQ
What is Silk Road Medical’s yearly revenue?
Silk Road Medical's yearly revenue for 2023 was $177.13M, representing an increase of 27.77% compared to 2022. The company's yearly revenue for 2022 was $138.64M, representing an increase of 36.62% compared to 2021. SILK's yearly revenue for 2021 was $101.48M, representing an increase of 34.89% compared to 2020.
What is Silk Road Medical’s quarterly revenue?
Silk Road Medical's quarterly revenue for Q1 2024 was $48.48M, a 2.57% increase from the previous quarter (Q4 2023), and a 20.81% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $47.27M, a 6.38% increase from the previous quarter (Q3 2023), and a 17.97% increase year-over-year (Q4 2022). SILK's quarterly revenue for Q3 2023 was $44.44M, a -1.91% decrease from the previous quarter (Q2 2023), and a 18.89% increase year-over-year (Q3 2022).
What is Silk Road Medical’s revenue growth rate?
Silk Road Medical's revenue growth rate for the last 3 years (2021-2023) was 74.56%, and for the last 5 years (2019-2023) was 179.59%.